PERSPECTA

News from every angle

← Back to headlines

ACADIA Pharmaceuticals Stock Upgraded to Buy

ACADIA (ACAD) stock has been upgraded to a 'Buy' rating after experiencing a recent pullback in the market.

2 May, 17:51 — 2 May, 17:51
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual121d ago

ACADIA (ACAD) Upgraded to Buy After Recent Pullback

Read full article →

Related Stories

South Korea Reports Record Export Surge in August Driven by Chip Demand

40m ago

Anthropic Secures $35 Billion Cloud Computing Deal With Nvidia-Backed Lambda

55m ago

Nigeria Reports 4.43 Percent Economic Growth in Second Quarter

1h ago

Hyundai Motor South Korean Union Approves New Wage Deal

1h ago